TIACA join hands with Pharma.Aero to prepare air cargo industry for COVID-19 Vaccine

In order to develop global guidance for the air cargo industry of optimal transportation of the COVID-19 vaccine, The International Air Cargo Association (TIACA) partnered with Pharma.Aero, once the vaccine is developed. The guidance will be developed gradually in four work packages through a joint working group to ensure feedback from all stakeholders in the supply chain of air cargo and pharmaceuticals.

The aim of this program is to provide the air cargo industry with more clarity of the demands, expectations and quality supply chain requirements, including but not restricted to critical trade lanes, air cargo capacity, handling and storage, track and trace requirements, for the transportation of the vaccines. At the same time, shippers will gain more understanding about the capabilities of the various logistics players. This will ensure that once the vaccine is available in the market, the air cargo industry will be ready to respond to the needs of the shippers and transport vaccines in optimal conditions to all corners of the globe.